Five genetic changes linked to pancreatic cancer risk
Researchers have discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer...
List view / Grid view
Researchers have discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer...
A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer...
An international team of scientists has developed a water-soluble “warped nanographene”, a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
Researchers have shown that by preventing loss of membrane asymmetry it's possible to control the immune response...
Researchers have uncovered the architecture of the spindle pole body in yeast...
A study in mice has suggested that iPS cells may train the immune system to attack or even prevent tumours...
Researchers in Spain provide specific examples of metabolomics applications in the field of clinical pharmacology and precision medicine, focusing on the therapeutic management of cancer.
Scientists have designed a new machine learning algorithm that uses time-series data to uncover underlying biological networks.
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumour growth.
Scientists have discovered why Huntington's is so toxic to cancer cells and harnessed it for a novel approach to treat cancer...
Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients...
Scientists offer important information for understanding de novo DNA methlylation...
New assay may allow screening for 'actionable' gene mutations in routinely acquired archival biopsies...
Dartmouth scientists have successfully uncovered a therapeutic approach that targets aggressive brain cancer stem cells and could lead to improved patient survival.
Scientists have rebuilt adenoviruses so that they effectively recognise and infect tumour cells.